July 8, 2021
Project Profiles Prefilled Apiject Injector

Project Profile: The RiteDose Corporation

In 2020, as part of the U.S. Government’s COVID-19 response, ApiJect entered into a long-term strategic partnership with The Ritedose Corporation (“TRC”). Together, we are able to make operational 45MM units per month of Blow-Fill-Seal fill-finish capacity for America’s COVID-19 response within 7 months at TRC in Columbia, South Carolina.

Might interest you

View All
Prefilled Apiject Injector
Transitioning your Drug Product or Vaccine into a Prefilled BFS Delivery Device
• Develop an understanding of the technical factors involved in transitioning your drug product, including material compatibility, process parameters, and their effects on drug stability and integrity. • Identify and resolve potential issues by utilizing prototyping and feasibility studies to ensure the...
BFS Technology
The Blow-Fill-Seal Process
The Blow-Fill-Seal (BFS) process is a widely used manufacturing technique in the pharmaceutical industry. It involves the simultaneous formation, filling, and sealing of containers, all within a single machine. This seamless and efficient process ensures the integrity and sterility of the final...
BFS Technology
The Evolution and Benefits of Blow-Fill-Seal Technology in Pharmaceuticals
Blow-Fill-Seal (BFS) technology has revolutionized the pharmaceutical and healthcare industries with its advanced aseptic processing capabilities. This innovative technique involves the simultaneous formation, filling, and sealing of containers, allowing for the production of sterile packaging in a highly efficient and controlled manner....